Altimmune CFO receives 18,750 shares on conversion
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Rhea-AI Filing Summary
At Altimmune, Inc. (ALT), Chief Financial Officer Gregory L. Weaver converted 18,750 restricted stock units into 18,750 common shares on November 11, 2026. He surrendered 5,672 shares solely to cover taxes associated with RSU vesting; those shares were reported at $1.93 per share. Weaver's reported post-transaction RSU balance was 37,500. No Rule 10b5-1 plan is reported.
Insider Trade Summary
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Exercise | Restricted Stock Units F1, F3 | 18,750 | $0.00 | $0.00 |
| Exercise | Common Stock, par value $0.0001 F1 | 18,750 | $0.00 | $0.00 |
| Tax Withholding | Common Stock, par value $0.0001 F2 | 5,672 | $1.93 | $11K |
Footnotes (3)
- F1. Each Restricted Stock Unit ("RSU") represents a contingent right to receive one share of Common Stock, par value $0.0001, when vested.
- F2. Vesting transaction: Shares surrendered to the Issuer solely to cover taxes associated with vesting of RSUs.
- F3. The RSUs become vested over four (4) years with 25% of the shares vesting on November 11, 2025, with the remainder vesting in equal annual installments for the following three (3) years, subject to the reporting person's continued service through the applicable vesting date, and have no expiration date.
Key Figures
Key Terms
Restricted Stock Unit financial
contingent right financial
vesting transaction financial
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.
AI-generated analysis. How Rhea-AI works. Not financial advice.